Search Results - "GREILSAMER, Charlotte"

Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial by Baciarello, Giulia, Delva, Remy, Gravis, Gwenaelle, Tazi, Youssef, Beuzeboc, Philippe, Gross-Goupil, Marine, Bompas, Emmanuelle, Joly, Florence, Greilsamer, Charlotte, Hon, Thierry Nguyen Tan, Barthelemy, Philippe, Culine, Stephane, Berdah, Jean Francois, Deblock, Mathilde, Ratta, Raffaele, Flechon, Aude, Cheneau, Caroline, Maillard, Aline, Martineau, Geraldine, Borget, Isabelle, Fizazi, Karim

“…Recent data suggest that cabazitaxel and docetaxel have similar activity but a different safety profile in the first-line metastatic castration-resistant…”
Get full text

CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients by Bailleux, Caroline, Arnaud, Antoine, Frenel, Jean-Sébastien, Chabaud, Sylvie, Bachelot, Thomas, You, Benoît, Stefani, Laëtitia, Tixidre, Claire Garnier, Simon, Hélène, Beal-Ardisson, Dominique, Jacquin, Jean-Philippe, Del Piano, Francesco, Lortholary, Alain, Cornea, Claudiu, Greilsamer, Charlotte, Largillier, Rémy, Brocard, Fabien, Legouffe, Eric, Atlassi, Mustapha, Hardy-Bessard, Anne-Claire, Heudel, Pierre-Etienne

“…Background The objective of the CHEOPS trial was to assess the benefit of adding aromatase inhibitor (AI) to metronomic chemotherapy, oral vinorelbine, 50 mg,…”
Get full text

Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab by Bureau, Mathilde, Chatellier, Thierry, Perennec, Tanguy, Goronflot, Thomas, Greilsamer, Charlotte, Chene, Anne-Laure, Affi, Raafet, Frampas, Eric, Bennouna, Jaafar, Pons-Tostivint, Elvire

“…Background Advanced non-small cell lung cancer (NSCLC) with a PD-L1 tumour proportion score ≥ 50% can be treated with pembrolizumab alone. Our aim was to…”
Get full text

Prognostic score for synchronous metastatic rectal cancer: A real-world study by Muzellec, Léa, Campion, Loïc, Bachet, Jean-Baptiste, Taieb, Julien, Fremont, Elodie, Senellart, Hélène, Moreau, Johanna, Bouché, Olivier, Garric, Marie, Guimbaud, Rosine, Greilsamer, Charlotte, Bodère, Anaïs, Lièvre, Astrid, Girot, Paul, Edeline, Julien, Tougeron, David, Bennouna, Jaafar, Touchefeu, Yann

“…Prognostic factors of metastatic rectal cancer are not well known. The objective of this study was to identify prognostic factors of overall survival (OS) in a…”
Get full text

Early phase trials at the "Institut de cancérologie de l'Ouest": Clinical outcome and validation of prognostic scores by Greilsamer, Charlotte, Campion, Loïc, Cabart, Mathilde, Gourmelon, Carole, Senellart, Hélène, Bennouna, Jaafar

“…Early phase therapeutic trials in oncology are being offered to an increasing number of patients. The objective of this study is to retrospectively evaluate…”
Get more information

Essais de phase précoce à l’Institut de cancérologie de l’Ouest : réponse au traitement et validation de scores pronostiques by Greilsamer, Charlotte, Campion, Loïc, Cabart, Mathilde, Gourmelon, Carole, Senellart, Hélène, Bennouna, Jaafar

“…Les essais thérapeutiques de phase précoce en oncologie sont proposés à un nombre croissant de patients. L’objectif de cette étude est d’évaluer…”
Get full text